Risikostratifizierte Therapie der Osteoporose

Literatur

• 1 Bauer D C, Ettinger B, Nevitt M C. et al . Risk for fracture in women with low serum levels of thyroid-stimulating hormone.  Ann Intern Med. 2001;  134 561-568
  Google Scholar
• 2 Bianchi G, Sambrook P. Oral nitrogen-containing bisphosphonates: a systematic review of randomized clinical trials and vertebral fractures.  Curr Med Res Opin. 2008;  24 2669-2677
  Google Scholar
• 3 Bolland M J, Barber P A, Doughty R N. et al . Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial.  BMJ. 2008;  336 262-266
  Google Scholar
• 4 Curtis J R, Westfall A O, Cheng H. et al . Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday.  Osteoporos Int. 2008;  19 1613-1620
  Google Scholar
• 5 DVO-Leitlinie 2009 zur Prophylaxe, Diagnostik und Therapie der Osteoporose bei Erwachsenen.  Osteologie. 2009;  18 304-328 http://www.dv-osteologie.org/dvo_leitlinien/dvo-leitlinie-2009
  Google Scholar
• 6 Gallagher A, Rietbrock S, Olson M. et al . Fracture outcomes related to persistence and compliance with oral bisphosphonates.  J Bone Miner Res. 2008;  23 1569-1575
  Google Scholar
• 7 Fournier M R, Targownik L E, Leslie W D. Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures.  Maturitas. 2009;  64 9-13
  Google Scholar
• 8 Holick M F, Chen T C. Vitamin D deficiency: a worldwide problem with health consequences.  Am J Clin Nutr. 2008;  87 1080S-1086S
  Google Scholar
• 9 Ito Z, Harada A, Matsui Y. et al . Can you diagnose for vertebral fracture correctly by plain X-ray?.  Osteoporos Int. 2006;  17 1584-1591
  Google Scholar
• 10 McCloskey E V, Johansson H, Oden A. et al . Ten-year fracture probability identifies women who will benefit from clodronate therapy-additional results from a double-blind, placebo-controlled randomised study.  Osteoporos Int. 2009;  20 811-817
  Google Scholar
• 11 Pfeilschifter J. Schmerztherapie bei Osteoporose.  Allgemeinarzt. 2007;  19 32-37
  Google Scholar
• 12 Saag K G, Shane E, Boonen S. et al . Teriparatide or alendronate in glucocorticoid-induced osteoporosis.  N Engl J Med. 2007;  357 2028-2039
  Google Scholar
• 13 Seeman E. Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?.  Bone. 2007;  41 308-317
  Google Scholar
• 14 Steingrimsdottir L, Gunnarsson O, Indridason O S. et al . Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake.  JAMA. 2005;  294 2336-2341
  Google Scholar
• 15 Tervo T, Nordström P, Neovius M. et al . Constant Adaptation of Bone to Current Physical Activity Level in Men: A 12-Year Longitudinal Study.  J Clin Endocrinol Metab. 2008;  93 4873-4879
  Google Scholar
• 16 van Brussel M S, Lems W F. Clinical relevance of diagnosing vertebral fractures by vertebral fracture assessment.  Curr Osteoporos Rep. 2009;  7 103-106
  Google Scholar

Prof. Dr. med. Johannes Pfeilschifter

Alfried Krupp Krankenhaus – Steele
Klinik für Innere Medizin III

Hellweg 100

45276 Essen

Phone: 0201/805-1847

Fax: 0201/805-2185

Email: Johannes.Pfeilschifter@krupp-krankenhaus.de